Concepedia

Paul H. Berg

PH

Statistics

Publications

18

Citations

1.6K

H-Index

14

Active since

1996

Affiliations

Eli Lilly (United States)(Current)

Eli Lilly (United Kingdom)

Medical University of South Carolina

Orlando Clinical Research Center

Indiana University – Purdue University Indianapolis

Paul H. Berg is an author at Eli Lilly (United States) specializing in pharmacotherapy, medicine, and pharmacology.

Publications per year

1996–2023

18

Publications

18

Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy

James R. Voelker, Paul H. Berg, Matthew J. Sheetz et al. · Journal of the American Society of Nephrology · 2016 · 273 citations

Medicine, Pharmacology, Pharmacotherapy +17

Lasmiditan is an effective acute treatment for migraine

Bernice Kuca, Stephen D. Silberstein, Linda Wietecha et al. · Neurology · 2018 · 267 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) Formation

Stephen J. Nicholls, Steven E. Nissen, Cynthia Griggs Fleming et al. · JAMA · 2023 · 184 citations · Full text

Life Sciences, Biochemistry, Pharmacology +16

Olanzapine Versus Ziprasidone: Results of a 28-Week Double-Blind Study in Patients With Schizophrenia

Alan Breier, Paul H. Berg, Jogin H. Thakore et al. · American Journal of Psychiatry · 2005 · 154 citations

Medicine, Pharmacotherapy, Psychiatry +17

Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis

Joerg Czekalla, Charles M. Beasley, Mary Anne Dellva et al. · The Journal of Clinical Psychiatry · 2001 · 120 citations

Medicine, Pharmacology, Pharmacotherapy +17

1–5 of 18